Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of ET-26 in Renal Impairment
NCT06747520Phase 1Completed
- Sponsor
- Jinzhou Ahon Pharmaceutical Co., Ltd.
- Start
- Nov 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of methoxyetomidate in general anesthesia (3 arms), sponsored by Jinzhou Ahon Pharmaceutical Co., Ltd. Primary endpoint: Pharmacokinetic parameters at 24 hours. Started Nov 2023; status: completed.
02
Drugs
methoxyetomidate
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT06747520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06747520.